Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Diagnostic and Statistical Manual of Mental Disorders (DSM)

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...

Treatment Strategies for Psychological Disorders

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.

Neuropsychiatric disease and treatment·2026

Same author

Is It Time for a Universal Outcome Measure to Deliver on the Promises of Interventional Psychiatry?

The American journal of psychiatry·2026

Same author

Derivation of an updated brief multivariable prediction model to detect panic-related anxiety in emergency department patients with cardiopulmonary complaints.

Frontiers in psychiatry·2026

Same author

Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trial.

Journal of affective disorders·2026

Same author

Factors associated with interpersonal retraumatization in children and adolescents: A prospective study.

Psychiatry research·2025

Same author

The trajectory of symptom change over the course of transcranial magnetic stimulation for major depressive disorder.

Brain stimulation·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Screening for major depression in private practice.

Ira H Bernstein¹, Burdette Wendt, Suhayl J Nasr

¹Department of Clinical Sciences, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9066, USA. Ira.Bernstein@utsouthwestern.edu

Journal of Psychiatric Practice

|April 3, 2009

Summary

This summary is machine-generated.

The Quick Inventory of Depressive Symptomatology (QIDS-SR16) demonstrated superior validity in assessing depression among outpatients compared to other scales. This self-report measure effectively captures core depressive symptoms without clinician involvement.

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Published on: January 17, 2025

Related Experiment Videos

Last Updated: Jun 24, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Published on: January 17, 2025

Area of Science:

Psychiatry
Clinical Psychology
Psychometrics

Background:

The Quick Inventory of Depressive Symptomatology (QIDS-SR16) is a self-report depression scale frequently compared to others.
Previous studies lacked data from large, single private psychiatric practices.
This study addresses this gap by evaluating the QIDS-SR16 against other measures in such a setting.

Purpose of the Study:

To compare the validity and reliability of the QIDS-SR16 with the Carroll Depression Rating Scale (CDRS-SR17) and the Symptom Check List-90 depression subscale (SCL-D13).
To assess these scales against a "gold standard" diagnostic tool, the Mini version of the Structured Clinical Interview for DSM-IV (MiniSCID).

Main Methods:

Utilized classical test theory for item and scale statistics.
Employed factor analysis for dimensionality assessment.
Applied the Samejima item response theory model for reliability and diagnostic comparisons.
Assessed validity using ANOVA effect sizes, ROC curves, and logistic regression models.

Main Results:

The QIDS-SR16 showed the strongest correlation with MiniSCID diagnoses, indicating high validity.
The SCL-D13 exhibited the highest reliability (alpha=0.91) and sensitivity for less depressed patients.
The CDRS-SR17 was most sensitive for severely depressed patients.
The QIDS-SR16 was consistently the most valid across multiple analytical methods.

Conclusions:

All three depression scales performed adequately in this clinical sample.
The QIDS-SR16 offers distinct advantages due to its design, focusing on core depression symptoms.
The QIDS-SR16 is a valid and effective self-report tool for assessing depression, not requiring clinician administration.